Galcanezumab Provides Consistent Efficacy Throughout the Dosing Interval Among Patients with Episodic and Chronic Migraine: A Post Hoc Analysis
Patricia Pozo‐Rosich(Vall d'Hebron Institut de Recerca), Eric Pearlman(University of California, San Francisco), Karen Samaan(Eli Lilly (United States)), Todd J. Schwedt(Mayo Clinic in Arizona), Mallikarjuna Rettiganti(Eli Lilly (United States)), Robert A. Nicholson(Eli Lilly (United States))
Cited by 12
Related Papers
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453
Neutrophil P2X7 receptors mediate NLRP3 inflammasome-dependent IL-1β secretion in response to ATP
|Nature Communications|2016|446